Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics

Sexually Transmitted Infections

Volumn 81, Issue 6, 2005, Pages 483-487

  Brabin, L ^a,b   Roberts, S A ^b   Fairbrother, E ^b   Mandal, D ^c   Higgins, S P ^d   Chandiok, S ^e   Wood, P ^f   Barnard, G ^g   Kitchener, H C ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^e WITHINGTON HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE GLUCURONIDE; MEDROXYPROGESTERONE ACETATE; PREGNANE DERIVATIVE; PREGNANEDIOL;

ADOLESCENT; AMENORRHEA; ARTICLE; CONDOM; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HORMONAL REGULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; OLIGOMENORRHEA; PH MEASUREMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VAGINA; VAGINITIS;

ADOLESCENT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; SEXUAL PARTNERS; SPECIMEN HANDLING; VAGINA; VAGINOSIS, BACTERIAL;

EID: 29144460172     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.014621     Document Type: Article

References (35)

1. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990;12:856-72.
2. Hill GB, St Claire KK, Gutman LT. Anaerobes predominate among the vaginal microflora of prepubertal girls. Clin Infect Dis 1995;20(Suppl 2):S269-70.
3. Keane FEA, Ison CA, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997;8:489-94.
4. Priestley CJF, Jones BM, Dhar J, et al. What is normal vaginal flora? Genitourin Med 1997;73:23-8.
5. Apter D. Development of the hypothalamic-pituitary-ovarian axis. Ann N Y Acad Sci 1997;816:9-21.
6. Stevens-Simon C, Jamison JA, McGregor JA, et al. Racial variation in vaginal pH among healthy sexually active adolescents. Sex Transm Dis 1994;21:168-72.
7. Lamont RF, Morgan DJ, Wilden SD, et al. Prevalence of bacterial vaginosis in women attending one of three general practices for routine cervical cytology. Int J STD AIDS 2000;11:495-8.
8. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003;36:663-8.
9. Cherpes TL, Meyn IA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003;37:319-24.
10. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998;12:1699-706.
11. Brabin L. Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously? BMJ 2001;323:394-5.
12. Brabin L, Fairbrother E, Mandal D, et al. Biological and hormonal markers of chlamydia, human papillomavirus and bacterial vaginosis among adolescents attending genitourinary medicine clinics. Sex Transm Infect 2005;81:128-32.
13. Duke PM, Litt IF, Gross RT. Adolescent self assessment of sexual maturation. Pediatrics 1980;66:918-20.
14. Wilcox MH, Reynolds MT, Hoy CM, et al. Combined cervical swab and urine specimens for PCR diagnosis of Chlamydia trachomatis infection. Sex Transm Infect 2000;76:177-78.
15. Behre HM, Kuhlage J, Gaßner C, et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 2000;15:2478-82.
16. De Roda Hunsman AM, Walboomers JMM, Van den Brule AJC, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
17. Mclaughlan JM, Seth R, Vautier G, et al. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol 1997;181:87-92.
18. Kesner JS, Knecht EA, Krieg EF, et al. Validations of time-resolved flouroimmunoassays for urinary estrone 3-glucuronide and pregnanediol 3-glucuronide. Steroids 1994;59:205-11.
19. Munro CJ, Stabenfeldt GT, Cragun JR, et al. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem 1991;7:838-44.
20. R Development Core Team. R: a language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2003 (www.R-project.org).
21. Eschenbach DA, Thwin SS, Patton DL, et al. Influence of the normal menstrual cycle on vaginal tissue, discharge and microflora. Clin Infect Dis 2000;30:901-7.
22. Boskey ER, Cone RA, Whaley KJ, et al. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 2001;16:1809-13.
23. Pybus V, Onderdonk AB. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes and Infect 1999;1:285-92.
24. Holzman JC, Leventhal JM, Qui H, and the BV Study Group, et al. Factors linked to bacterial vaginosis in non pregnant women. Am J Public Health 2001;91:1664-70.
25. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 2001;185:380-85.
26. Evans A. Prevention of chronically recurrent bacterial vaginosis by medical management of perimenopausal menorrhagia. Abstract 013. Sex Transm Infect 2003;79(Suppl 1)A11.
27. Hallberg L, Höghdahl AM, Nilsson L, et al. Menstrual blood loss-a population study. Acta Obstet Gynecol Scand 1966;45:25-45.
28. Smart S, Singal A, Mindel A. Social and sexual risk factors for bacterial vaginosis. Sex Transm Infect 2004;80:58-62.
29. Shoubnikova M, Hellberg D, Nilsson S, et al. Contraceptive use in women with bacterial vaginosis. Contraception 1997;55:355-8.
30. Mårdh P-A, Tchoudomirova K, Elshibly S, et al. Symptoms and signs in single and mixed genital infections. Int J Gynecol Obstet 1998;63:145-52.
31. Stergachis A, Scholes D, Heidrich FE, et al. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993;138:143-53.
32. Morrison CS, Bright P, Wong EL, et al. Hormonal contraceptive use, cervical ectopy and the acquisition of cervical infections. Sex Transm Dis 2004;31:561-7.
33. Peeters M, Piot P. Adhesion of Gardnerella vaginalis to vaginal epithelial cells: variables affecting adhesion and inhibition by metronidazole. Genitourin Med 1985;61:391-5.
34. Schwebke JR, Schulien MB, Zajackowski M. Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis. Infec Dis Obstet Gynecol 1995;3:199-22.
35. Shafer MA, Sweet RL, Ohm-Smith MJ, et al. Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr 1985;107:974-81.